<DOC>
	<DOC>NCT00625781</DOC>
	<brief_summary>The purpose of this study is to evaluate if treatment (insulin or diet) of pregnant women with impaired glucose tolerance (75-g OGTT with a fasting P-gluc &lt;7.0 mmol/l and 2 h P-gluc &gt;10.0 and &lt;12.2 mmol/l) close to normoglycemia reduces childrenÂ´s birth weight and neonatal morbidity. There will be a focus on treatment according to specific goals and separate follow-up regimes for the children and women post partum.</brief_summary>
	<brief_title>Treatment of Impaired Glucose Tolerance in Pregnancy</brief_title>
	<detailed_description />
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Fetal Macrosomia</mesh_term>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<criteria>Women with 75g OGTT result : fasting capillary plasma &lt;=7.0 mmol/l and/or 2 h value &gt;= 12.2 mmol/l Multiple pregnancy Pregestational Diabetes</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Gestational diabetes mellitus</keyword>
	<keyword>Impaired glucose Tolerance</keyword>
	<keyword>Pregnancy</keyword>
	<keyword>Fetal macrosomia</keyword>
	<keyword>Treatment</keyword>
	<keyword>Perinatal morbidity</keyword>
</DOC>